Complex chimerism: Pregnancy after solid organ transplantation

Chimerism

Volumn 4, Issue 3, 2013, Pages

  Ma, Kimberly K ^a   Petrof, Margaret G ^b   Coscia, Lisa A ^c   Armenti, Vincent T ^c   Adams Waldorf, Kristina M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c National Transplantation Pregnancy Registry   (United States)

Author keywords

Chimerism; Graft rejection; Kidney; Liver; Microchimerism; Pregnancy; Tolerance; Transplant; Transplantation

Indexed keywords

ESTROGEN; HLA ANTIGEN; INTERLEUKIN 10;

ANTIBODY DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL POPULATION; CELL TRANSPORT; CHRONIC GRAFT REJECTION; CROSS REACTION; CYTOKINE PRODUCTION; FETUS CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MICROCHIMERISM; MOLECULAR DYNAMICS; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRE B LYMPHOCYTE; PRE T LYMPHOCYTE; PREGNANCY; PREGNANCY OUTCOME; PUERPERIUM; RISK ASSESSMENT; RISK FACTOR; CHIMERA; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; GENETICS; GRAFT REJECTION; IMMUNOLOGY; KIDNEY; LIVER; PREECLAMPSIA; TOLERANCE; TRANSPLANT; TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

CHIMERISM; GRAFT REJECTION; KIDNEY; LIVER; MICROCHIMERISM; PREGNANCY; TOLERANCE; TRANSPLANT; TRANSPLANTATION;

CHIMERISM; FEMALE; FETUS; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; MATERNAL-FETAL EXCHANGE; ORGAN TRANSPLANTATION; PRE-ECLAMPSIA; PREGNANCY; TRANSPLANTATION TOLERANCE;

EID: 84880810936     PISSN: 19381956     EISSN: 19381964     Source Type: Journal    
DOI: 10.4161/chim.25401     Document Type: Article

References (82)

1. Murray JE, Merrill J P, Dammin GJ, Dealy JB Jr., Walter C W, Brooke MS, et al. Study on transplantation immunity after total body irradiation: clinical and experimental investigation. Surgery 1960; 48:272-284; PMID:14425430
2. Murray JE, Reid DE, Harrison JH, Merrill J P. Successful pregnancies after human renal transplantation. N Engl J Med 1963; 269:341-343; PMID:13936776; http://dx.doi.org/10.1056/NEJM196308152690704
3. Tafuri A, Alferink J, Möller P, Hämmerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 1995; 270:630-633; PMID:7570020; http://dx.doi.org/10.1126/science.270.5236.630
4. Lissauer D, Piper K, Goodyear O, Kilby MD, Moss PA. Fetal-specific CD8+ cytotoxic T cell responses develop during normal human pregnancy and exhibit broad functional capacity. J Immunol 2012; 189:1072-1080; PMID:22685312; http://dx.doi.org/10.4049/jimmu-nol.1200544
5. Bonney EA, Matzinger P. The maternal immune system's interaction with circulating fetal cells. J Immunol 1997; 158:40-47; PMID:8977173
6. Lambert NC, Evans PC, Hashizumi TL, Maloney S, Gooley T, Furst DE, et al. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1;0501: implications in autoimmunity. J Immunol 2000; 164:5545-5548; PMID:10820227
7. Nelson JL. The otherness of self: microchimerism in health and disease. Trends Immunol 2012; 33:421-427; PMID:22609148; http://dx.doi.org/10.1016/j. it.2012.03.002
8. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2004; 291:1127-1131; PMID:14996783; http://dx.doi.org/10.1001/jama.291.9.1127
9. De Moor G, De Bock G, Noens L, De Bie S. A new case of human chimerism detected after pregnancy: 46, XY karyotype in the lymphocytes of a woman. Acta Clin Belg 1988; 43:231-235; PMID:3414310
10. Lee TH, Paglieroni T, Ohto H, Holland P V, Busch M P. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999; 93:3127-3139; PMID:10216112
11. Bianchi DW, Farina A, Weber W, Delli-Bovi LC, Deriso M, Williams JM, et al. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 2001; 184:703-706; PMID:11262475; http://dx.doi.org/10.1067/mob.2001.111072
12. Peterson SE, Nelson JL, Guthrie KA, Gadi VK, Aydelotte TM, Oyer DJ, et al. Prospective assessment of fetal-maternal cell transfer in miscarriage and pregnancy termination. Hum Reprod 2012; 27:2607-2612; PMID:22752611; http://dx.doi.org/10.1093/humrep/ des244
13. Adams KM, Lambert NC, Heimfeld S, Tylee TS, Pang JM, Erickson TD, et al. Male DNA in female donor apheresis and CD34-enriched products. Blood 2003; 102:3845-3847; PMID:12869496; http://dx.doi. org/10.1182/blood-2003-05-1570
14. Davies T F. The thyroid immunology of the postpartum period. Thyroid 1999; 9:675-684; PMID:10447014; http://dx.doi.org/10.1089/thy.1999.9.675
15. Chan GW, Mandel SJ. Therapy insight: management of Graves' disease during pregnancy. Nat Clin Pract Endocrinol Metab 2007; 3:470-478; PMID:17515891; http://dx.doi.org/10.1038/ncpendmet0508
16. Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis. Mayo Clin Proc 1938; 13:161-167
17. Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med 2010; 363:1451-1462; PMID:20925547;http://dx.doi.org/10.1056/ NEJMra0902927
18. National Transplantation Pregnancy Registry (NTPR) 2011 Annual Report. Philadelphia, PA: Thomas Jefferson University; 2011.
19. Müller CA, Markovic-Lipkovski J, Risler T, Bohle A, Müller GA. Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis. Kidney Int 1989; 35:116-124; PMID:2468811; http:// dx.doi.org/10.1038/ki.1989.16
20. Daar AS, Fuggle SV, Fabre J W, Ting A, Morris PJ. The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 1984; 38:287-292; PMID:6591601; http://dx.doi. org/10.1097/00007890-198409000-00018
21. Navarro V, Herrine S, Katopes C, Colombe B, Spain C V. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database. Liver Transpl 2006; 12:652-658; PMID:16555339; http://dx.doi.org/10.1002/lt.20680
22. Fleming KA, McMichael A, Morton JA, Woods J, McGee JO. Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol 1981; 34:779-784; PMID:7021603; http:// dx.doi.org/10.1136/jcp.34.7.779
23. Fukusato T, Gerber MA, Thung SN, Ferrone S, Schaffner F. Expression of HLA class I antigens on hepatocytes in liver disease. Am J Pathol 1986; 123:264-270; PMID:2422944
24. Chih S, Chruscinski A, Ross HJ, Tinckam K, Butany J, Rao V. Antibody-mediated rejection: an evolving entity in heart transplantation. J Transplant 2012; 2012:210210; PMID:22545200; http://dx.doi. org/10.1155/2012/210210
25. Stewart S, Winters G L, Fishbein M C, Tazelaar H D, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24:1710-1720; PMID:16297770; http://dx.doi.org/10.1016/j.healun.2005.03.019
26. Neil D A, Hübscher S G. Current views on rejection pathology in liver transplantation. Transpl Int 2010; 23:971-983; PMID:20723179; http://dx.doi. org/10.1111/j.1432-2277.2010.01143.x
27. Adams K M, Yan Z, Stevens A M, Nelson J L. The changing maternal "self" hypothesis: a mechanism for maternal tolerance of the fetus. Placenta 2007; 28:378-382; PMID:16934327; http://dx.doi.org/10.1016/j.pla-centa.2006.07.003
28. Taglauer E S, Adams Waldorf K M, Petroff M G. The hidden maternal-fetal interface: events involving the lymphoid organs in maternal-fetal tolerance. Int J Dev Biol 2009; 15; In press; PMID:19876825
29. Bevan M J. Cross-priming. Nat Immunol 2006; 7:363-365; PMID:16550200; http://dx.doi.org/10.1038/ ni0406-363
30. Van Halteren A G, Jankowska-Gan E, Joosten A, Blokland E, Pool J, Brand A, et al. Naturally acquired tolerance and sensitization to minor histocompat-ibility antigens in healthy family members. Blood 2009; 114:2263-2272; PMID:19506299; http://dx.doi.org/10.1182/blood-2009-01-200410
31. Verdijk R M, Kloosterman A, Pool J, van de Keur M, Naipal A M, van Halteren A G, et al. Pregnancy induces minor histocompatibility antigen-specific cyto-toxic T cells: implications for stem cell transplantation and immunotherapy. Blood 2004; 103:1961-1964; PMID:14592836; http://dx.doi.org/10.1182/blood-2003-05-1625
32. Holland O J, Linscheid C, Hodes H C, Nauser T L, Gilliam M, Stone P, et al. Minor histocompatibil-ity antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal allo-reactivity to the fetus. Am J Pathol 2012; 180:256-266; PMID:22079431; http://dx.doi.org/10.1016/j. ajpath.2011.09.021
33. Taglauer E S, Adams Waldorf K M, Petroff M G. The hidden maternal-fetal interface: events involving the lymphoid organs in maternal-fetal tolerance. Int J Dev Biol 2010; 54:421-430; PMID:19876825; http:// dx.doi.org/10.1387/ijdb.082800et
34. Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 2011; 1221:80-87; PMID:21401634; http://dx.doi. org/10.1111/j.1749-6632.2010.05938.x
35. Romero R, Gomez R, Ghezzi F, Yoon B H, Mazor M, Edwin S S, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998; 179:186-193; PMID:9704786; http://dx.doi.org/10.1016/S0002-9378(98)70271-6
36. Prins J R, Gomez-Lopez N, Robertson S A. Interleukin-6 in pregnancy and gestational disorders. J Reprod Immunol 2012; 95:1-14; PMID:22819759; http://dx.doi.org/10.1016/j.jri.2012.05.004
37. Erlebacher A, Vencato D, Price K A, Zhang D, Glimcher L H. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest 2007; 117:1399-1411; PMID:17446933; http:// dx.doi.org/10.1172/JCI28214
38. Starzl T E, Demetris A J, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339:1579-1582; PMID:1351558; http://dx.doi.org/10.1016/0140-6736(92)91840-5
39. Chan W F, Gurnot C, Montine T J, Sonnen J A, Guthrie K A, Nelson J L. Male microchimerism in the human female brain. PLoS One 2012; 7:e45592; PMID:23049819; http://dx.doi.org/10.1371/journal. pone.0045592
40. Stevens A M, Hermes H M, Rutledge J C, Buyon J P, Nelson J L. Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 2003; 362:1617-1623; PMID:14630442; http://dx.doi.org/10.1016/S0140-6736(03)14795-2
41. Stevens A M, McDonnell W M, Mullarkey M E, Pang J M, Leisenring W, Nelson J L. Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab Invest 2004; 84:1603-1609; PMID:15502859; http://dx.doi.org/10.1038/labin-vest.3700193
42. Nelson J L, Gillespie K M, Lambert N C, Stevens A M, Loubiere L S, Rutledge J C, et al. Maternal microchi-merism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci U S A 2007; 104:1637-1642; PMID:17244711; http://dx.doi.org/10.1073/pnas.0606169104
43. Gammill H S, Nelson J L. Naturally acquired microchimerism. Int J Dev Biol 2010; 54:531-543; PMID:19924635;http://dx.doi.org/10.1387/ ijdb.082767hg
44. Gadi V K. Fetal microchimerism in breast from women with and without breast cancer. Breast Cancer Res Treat 2010; 121:241-244; PMID:19768535; http://dx.doi.org/10.1007/s10549-009-0548-1
45. Dutta P, Burlingham W J. Correlation between post transplant maternal microchimerism and tolerance across MHC barriers in mice. Chimerism 2011; 2:78-83; PMID:22163065; http://dx.doi.org/10.4161/ chim.18083
46. Gutman J A, Turtle CJ, Manley T J, Heimfeld S, Bernstein ID, Riddell SR, et al. Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit. Blood 2010; 115:757-765; PMID:19822900; http://dx.doi.org/10.1182/blood-2009-07-228999
47. Gammill H S, Guthrie K A, Aydelotte T M, Adams Waldorf K M, Nelson J L. Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host? Blood 2010; 116:2706-2712; PMID:20628146; http://dx.doi.org/10.1182/blood-2010-02-270942
48. Burlingham W J, Grailer A P, Heisey D M, Claas F H, Norman D, Mohanakumar T, et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 1998; 339:1657-1664; PMID:9834302; http://dx.doi.org/10.1056/NEJM199812033392302
49. Molitor-Dart M L, Andrassy J, Kwun J, Kayaoglu H A, Roenneburg D A, Haynes L D, et al. Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. J Immunol 2007; 179:6749-6761; PMID:17982065
50. Nelson J L, Hughes K A, Smith A G, Nisperos B B, Branchaud A M, Hansen J A. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993; 329:466-471; PMID:8332151; http://dx.doi. org/10.1056/NEJM199308123290704
51. Kane S, Kisiel J, Shih L, Hanauer S. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am J Gastroenterol 2004; 99:1523-1526; PMID:15307871; http://dx.doi.org/10.1111/j.1572-0241.2004.30472.x
52. Lin H, Mosmann T R, Guilbert L, Tuntipopipat S, Wegmann T G. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573; PMID:8409418
53. Lang T J. Estrogen as an immunomodulator. Clin Immunol 2004; 113:224-230; PMID:15507385; http:// dx.doi.org/10.1016/j.clim.2004.05.011
54. Segal B M, Glass D D, Shevach E M. Cutting Edge: IL-10-producing CD4+ T cells mediate tumor rejection. J Immunol 2002; 168:1-4; PMID:11751938
55. Wan R, Tang L, Shan R, Zeng L, Chen H, Gao L. Humoral immunity-mediated chronic rejection in liver transplantation is associated with predominant IL-10 expression. [Elite Ed]. Front Biosci (Elite Ed) 2012; 4:2121-2130;PMID:22202024
56. Qian S, Li W, Li Y, Fu F, Lu L, Fung J J, et al. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation 1996; 62:1709-1714;PMID:8990348; http://dx.doi. org/10.1097/00007890-199612270-00002
57. Ginwalla M, Pando M J, Khush K K. Pregnancy-related human leukocyte antigen sensitization leading to cardiac allograft vasculopathy and graft failure in a heart transplant recipient: a case report. Transplant Proc 2013; 45:800-802; PMID:23498823; http://dx.doi. org/10.1016/j.transproceed.2012.10.038
58. O'Boyle P J, Smith J D, Danskine A J, Lyster H S, Burke M M, Banner N R. De novo HLA sensitization and antibody mediated rejection following pregnancy in a heart transplant recipient. Am J Transplant 2010; 10:180-183; PMID:19951281; http://dx.doi.org/10.1111/j.1600-6143.2009.02875.x
59. Van Rood J J, Eernisse J G, Van Leeuwen A. Leucocyte antibodies in sera from pregnant women. Nature 1958; 181:1735-1736;PMID:13566127; http://dx.doi.org/10.1038/1811735a0
60. Deshpande N A, James N T, Kucirka L M, Boyarsky B J, Garonzik-Wang J M, Cameron A M, et al. Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis. Liver Transpl 2012; 18:621-629;PMID:22344967; http://dx.doi.org/10.1002/ lt.23416
61. Deshpande N A, James N T, Kucirka L M, Boyarsky B J, Garonzik-Wang J M, Montgomery R A, et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am J Transplant 2011;11:2388-2404;PMID:21794084; http://dx.doi. org/10.1111/j.1600-6143.2011.03656.x
62. Madazli R, Aydin S, Uludag S, Vildan O, Tolun N. Maternal plasma levels of cytokines in normal and pre-eclamptic pregnancies and their relationship with dia-stolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003; 82:797-802; PMID:12911439; http://dx.doi.org/10.1034/j.1600-0412.2003.00206.x
63. Takacs P, Green K L, Nikaeo A, Kauma S W. Increased vascular endothelial cell production of interleu-kin-6 in severe preeclampsia. Am J Obstet Gynecol 2003; 188:740-744;PMID:12634650; http://dx.doi. org/10.1067/mob.2003.134
64. Vince G S, Starkey P M, Austgulen R, Kwiatkowski D, Redman C W. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102:20-25; PMID:7833306; http://dx.doi.org/10.1111/j.1471-0528.1995.tb09020.x
65. Annual Report: National Transplantation Pregnancy Registry. Philadelphia, PA: Thomas Jefferson University; 2011. 2011
66. Gabbe SG, Niebyl JR, Simpson JL, et al. Obstetrics: Normal and Problem Pregnancies. Philadelphia, PA: Elsevier, Inc.; 2012.
67. Davies P F, Dewey C F Jr., Bussolari S R, Gordon E J, Gimbrone M A Jr. Influence of hemodynamic forces on vascular endothelial function. In vitro studies of shear stress and pinocytosis in bovine aortic cells. J Clin Invest 1984; 73:1121-1129; PMID:6707208; http:// dx.doi.org/10.1172/JCI111298
68. Li R, Jen N, Yu F, Hsiai T K. Assessing mitochon-drial redox status by flow cytometric methods: vascular response to fluid shear stress. Curr Protoc Cytom 2011; Chapter 9:37; PMID:21965108
69. Bianchi D W, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci I S A. Jan 23 1996;93(2):705-708.
70. Nicholson W K, Robinson K A, Smallridge R C, Ladenson P W, Powe N R. Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid 2006; 16:573-582; PMID:16839259; http://dx.doi. org/10.1089/thy.2006.16.573
71. Finkelsztejn A, Brooks J B, Paschoal F M Jr., Fragoso Y D. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 2011; 118:790-797; PMID:21401856; http://dx.doi.org/10.1111/j.1471-0528.2011.02931.x
72. Miller L, Alley E W, Murphy W J, Russell S W, Hunt J S. Progesterone inhibits inducible nitric oxide syn-thase gene expression and nitric oxide production in murine macrophages. J Leukoc Biol 1996; 59:442-450; PMID:8604025
73. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler S F, et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004; 173:2227-2230; PMID:15294932
74. Thiagarajan K T, Arakali SR, Mealey KJ, et al. Safety Considerations: Breastfeeding After Transplantation. Prog Transplant 2013; 23:137-46
75. James E, Chai JG, Dewchand H, Macchiarulo E, Dazzi F, Simpson E. Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood 2003; 102:388-393; PMID:12649154; http://dx.doi.org/10.1182/blood-2002-10-3170
76. Piper K P, McLarnon A, Arrazi J, Horlock C, Ainsworth J, Kilby MD, et al. Functional HY-specific CD8+ T cells are found in a high proportion of women following pregnancy with a male fetus. Biol Reprod 2007; 76:96-101; PMID:16988213; http://dx.doi. org/10.1095/biolreprod.106.055426
77. Jiang S P, Vacchio M S. Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft". J Immunol 1998; 160:3086-3090; PMID:9531261
78. Taglauer ES, Yankee TM, Petroff MG. Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy. J Reprod Immunol 2009; 80:12-21; PMID:19368976; http://dx.doi.org/10.1016/j. jri.2008.12.001
79. Billingham RE, Silvers WK, Wilson DB. A Second Study on the H-Y Transplantation Antigen in Mice. Proc R Soc Lond B Biol Sci 1965; 163:61-89; PMID:14338494; http://dx.doi.org/10.1098/ rspb.1965.0060
80. Smith RN, Powell AE. The adoptive transfer of pregnancy-induced unresponsiveness to male skin grafts with thymus-dependent cells. J Exp Med 1977; 146:899-904; PMID:330791; http://dx.doi. org/10.1084/jem.146.3.899
81. Bonilla W V, Geuking MB, Aichele P, Ludewig B, Hengartner H, Zinkernagel RM. Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest 2006; 116:156-162; PMID:16395404; http://dx.doi.org/10.1172/JCI26565
82. Maloney S, Smith A, Furst DE, et al. Microchimerismn of maternal origin persists into adult life. J Clin Invest. Jul 1999;104(1):41-47.